With All U Healths extensive experience with these peptides, we are available to discuss all the options available for your weight loss journey
At the same time, your neurologist can evaluate how GLP-1 therapy might fit into your MS care
The FDA-approved labeling for semaglutide and tirzepatide doesn't specify a maximum treatment duration, suggesting long-term use is an acceptable clinical approach for appropriate patients
This article provides evidence-based strategies for managing GLP-1-related headaches, from immediate relief measures to long-term prevention, whilst highlighting when medical review becomes necessary
Published October 8, 2012
Some patients may need ongoing treatment to maintain their weight loss, as discontinuing the medication can lead to appetite returning to previous levels